Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BMcV who wrote (2788)	5/17/1999 7:45:00 AM
From: BMcV	Read Replies (3) of 10280

Looking more closely at the data, it looks to me like the results compared to Loratadine (Claritin) are somewhat ambiguous, making the efficacy comparable to slightly better. There were two studies, each over both 12 and 24 hours. A 30 mg dose of Nori was better than Lori in both cases, but only slightly so in the second study. sepracor.com Over 24 hours, Nori was quite a bit better in the first study, particularly over time: sepracor.com but not quite as good in the second study: sepracor.com Allergy studies are notoriously problematic, since the symptomology is so subjective. Lots of people report no results with popular medications, better results with placebo, etc. Still, owning the rights to a drug that is now proven to be at least as effective as Claritin isn't a bad place to be. Glaxo keeps coming up as a possible partner, given their involvement in respiratory therapeutics and lack of an antihistamine. I wonder if some generic shop like Mylan might not be a good partner, not the least since they could be a better fit culturally.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next